When activation of the canonical NF-κB pathway in Prx1+ skin fibroblasts is blocked by deletion of the Ikkb gene, cutaneous manifestations of AD occur, leading simultaneously to an increase in CCL11 expression (Ko et al. 2022). The gene discussed is CCL11; the disease is Alzheimer disease.